Ethics approval and consent to participate {24}
The MIDEX MRI study has been approved by the ethics committee of Erasme Hospital on the 12th of August 2022 (P2021/659) and by the ethics committee of H.U.D.E.R.F. on the 5th of August 2022 (EudraCT 2021–004456-42; file CEH n°112/21). The trial has also been approved by the federal agency for medicines and health products on the 21st of June 2022. Informed consent to participate will be obtained from all participants.